These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 17692211)
21. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France. Descamps D; Chaix ML; Montes B; Pakianather S; Charpentier C; Storto A; Barin F; Dos Santos G; Krivine A; Delaugerre C; Izopet J; Marcelin AG; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Tamalet C; Cottalorda J; Desbois D; Calvez V; Brun-Vezinet F; Masquelier B; Costagliola D; J Antimicrob Chemother; 2010 Dec; 65(12):2620-7. PubMed ID: 20965891 [TBL] [Abstract][Full Text] [Related]
22. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations. Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L; PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948 [TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy. Santoro MM; Alteri C; Ronga L; Flandre P; Fabeni L; Mercurio F; D'Arrigo R; Gori C; Palamara G; Bertoli A; Forbici F; Salpini R; Boumis E; Tozzi V; Visco-Comandini U; Zaccarelli M; Van Houtte M; Pattery T; Narciso P; Antinori A; Ceccherini-Silberstein F; Perno CF AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1285-93. PubMed ID: 22417570 [TBL] [Abstract][Full Text] [Related]
24. Limited increase in primary HIV-1C drug resistance mutations in treatment naïve individuals in Ethiopia. Huruy K; Maier M; Mulu A; Liebert UG J Med Virol; 2015 Jun; 87(6):978-84. PubMed ID: 25649964 [TBL] [Abstract][Full Text] [Related]
25. HIV transmitted drug resistance in adult and pediatric populations in Panama. Castillo J; Arteaga G; Mendoza Y; Martínez AA; Samaniego R; Estripeaut D; Page KR; Smith RE; Sosa N; Pascale JM Rev Panam Salud Publica; 2011 Dec; 30(6):649-56. PubMed ID: 22358417 [TBL] [Abstract][Full Text] [Related]
26. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations. Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857 [TBL] [Abstract][Full Text] [Related]
27. Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy. Santoro MM; Svicher V; Gori C; Zaccarelli M; Tozzi V; Forbici F; D'Arrigo R; Trotta MP; Bellocchi MC; Visco-Comandini U; Cenci A; Bertoli A; Narciso P; Antinori A; Perno CF; Ceccherini-Silberstein F New Microbiol; 2006 Apr; 29(2):89-100. PubMed ID: 16841549 [TBL] [Abstract][Full Text] [Related]
28. Primary drug resistance in antiretroviral-naïve injection drug users. Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493 [TBL] [Abstract][Full Text] [Related]
29. Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes. Anta L; Blanco JL; Llibre JM; García F; Pérez-Elías MJ; Aguilera A; Pérez-Romero P; Caballero E; Vidal C; Cañizares A; Gutiérrez F; Dalmau D; Iribarren JA; Soriano V; de Mendoza C; J Antimicrob Chemother; 2013 Sep; 68(9):1994-2002. PubMed ID: 23629015 [TBL] [Abstract][Full Text] [Related]
30. Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco. Cavalcanti AM; Brito AM; Salustiano DM; Lima KO; Silva SP; Diaz RS; Lacerda HR Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):450-7. PubMed ID: 22666853 [TBL] [Abstract][Full Text] [Related]
31. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain. Muñoz M; Carmona R; Pérez-Alvarez L; Cilla G; Suarez MD; Delgado E; Contreras G; Corral J; de Goicoetxea MJ; Medrano L; Lezaún MJ; Nájera R; J Clin Virol; 2005 Jul; 33(3):224-9. PubMed ID: 15911444 [TBL] [Abstract][Full Text] [Related]
32. High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger. Charpentier C; Bellecave P; Cisse M; Mamadou S; Diakite M; Peytavin G; Tchiombiano S; Teisseire P; Pizarro L; Storto A; Brun-Vézinet F; Katlama C; Calvez V; Marcelin AG; Masquelier B; Descamps D Antivir Ther; 2011; 16(3):429-33. PubMed ID: 21555827 [TBL] [Abstract][Full Text] [Related]
33. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy. Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463 [TBL] [Abstract][Full Text] [Related]
34. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis. de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049 [TBL] [Abstract][Full Text] [Related]
35. Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy. Jlizi A; Ben Ammar El Gaaied A; Slim A; Tebourski F; Ben Mamou M; Ben Chaabane T; Letaief-Omezzine A; Chakroun M; Garbouj M; Ben Rejeb S Arch Virol; 2008; 153(6):1103-8. PubMed ID: 18483694 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and patterns of HIV transmitted drug resistance in Guatemala. Avila-Ríos S; Mejía-Villatoro CR; García-Morales C; Soto-Nava M; Escobar I; Mendizabal R; Girón A; García L; Reyes-Terán G Rev Panam Salud Publica; 2011 Dec; 30(6):641-8. PubMed ID: 22358416 [TBL] [Abstract][Full Text] [Related]
37. [Prevalence of antiretroviral drug resistance among previously untreated Spanish patients infected with HIV]. Guerrero A; Cañizares A; Tomás S; Velasco D; Cartelle M; Enferm Infecc Microbiol Clin; 2005 Dec; 23(10):605-8. PubMed ID: 16324550 [TBL] [Abstract][Full Text] [Related]
38. [Prevalence of drug resistance mutations among antiretroviral drug-naive HIV-1-infected patients in China]. Si XF; Huang HL; Wei M; Guan Q; Song YH; Ma PF; Quan Y; Xing H; Shao YM Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):308-11. PubMed ID: 15650776 [TBL] [Abstract][Full Text] [Related]
39. HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization. Kagan R; Winters M; Merigan T; Heseltine P AIDS Res Hum Retroviruses; 2004 Jan; 20(1):1-9. PubMed ID: 15000693 [TBL] [Abstract][Full Text] [Related]
40. Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy. Aleman S; Söderbärg K; Visco-Comandini U; Sitbon G; Sönnerborg A AIDS; 2002 May; 16(7):1039-44. PubMed ID: 11953470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]